Abstract
Somatic mosaicism in genetic disease generally results from a de novo deleterious mutation during embryogenesis. We now describe a somatic mosaicism due to the unusual mechanism of in vivo reversion to normal of an inherited mutation. The propositus was an adenosine deaminase–deficient (ADA−) child with progressive clinical improvement and unexpectedly mild biochemical and immunologic abnormalities. Mosaicism due to reversion was evidenced by absence of a maternally transmitted deleterious mutation in 13/15 authenticated B cell lines and in 17% of single alleles cloned from blood DMA, despite retention of a maternal ‘private’ ADA polymorphism linked to the mutation. Establishment of significant somatic mosaicism following reversion to normal could modify any disorder in which revertant cells have a selective advantage.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hershfield, M.S. & Mitchell, B.S. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. in The Metabolic Basis of Inherited Disease 7th Edn. (eds Scriver, C., Beaudet, A.L, Sly, W.S. & Valle, D.) 1725–1768 (McGraw Hill, New York, 1995).
Hirschhorn, R. Adenosine deaminase deficiency. in Immunodeficiencies (eds Rosen, F.S. & Seligmann, M.) 177–196 (Harwood Academic Press, London, 1993).
Hirschhorn, R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediat. Res. 33, S35–41 (1993).
Hirschhorn, R. Adenosine deaminase deficiency: molecular basis and recent developments. Clin. Immun. Immunopathol. 76, S219–S226 (1995).
Shovlin, C.L. et al. A.D.B. Adult presentation of adenosine deaminase deficiency. Lancet 341, 1471 (1993).
Hirschhorn, R., Roegner, V., Jenkins, T., Seaman, C., Piomelli, S. & Borowsky, W. Erythrocyte adenosine deaminase deficiency without immunodeficiency: Evidence for an unstable mutant enzyme. J. Clin. Invest. 64, 1130–1139 (1979).
Hirschhorn, R., Tzall, S., Ellenbogen, A. & Orkin, S.H. Identification of a point mutation resulting in a heat labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency. J. Clin. Invest. 83, 497–501 (1989).
Hirschhorn, R. Genetic mosaicism: What Gregor Mendel didn't know (Editorial) J. Clin. Invest. 95, 443–444 (1995).
Hirschhorn, R., Israni, A., Yang, D.R. & Ownby, D. Somatic mosaicism for a newly identified splice site mutation in a patient with adenosine deaminase deficient immunodeficency (ADA−CID) and spontaneous clinical recovery. Am. J. Hum. Genet. 55, 59–68 (1994).
Kurlandsky, L.E., Webb, P. & Hirschhorn, R. Partial adenosine deaminase deficiency in an immunodeficient child. Pediat. Asthma, Allergy Immunol. 7, 51–55 (1993).
Santisteban, I. et al. Novel splicing, missense and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease: contribution of genotype to phenotype. J. Clin. Invest. 92, 2291–2302 (1993).
Santisteban, I. et al. Four new adenosine deaminase mutations altering a zinc-binding histidine, two conserved alanines and a 5′ splice site. Hum. Mutat. 5, 243–250 (1995).
Hirschhorn, R., Tzall, S., Ellenbogen, A. & Eng, F. Hot spot mutations in adenosine deaminase (ADA) deficiency. Proc. Natl Acad. Sci. USA 87, 6171–6175 (1990).
Hirschhorn, R. Identification of two new missense mutations (R156C and S291L) in two ADA-SCID patients unusual for response to therapy with partial exchange transfusions. Hum. Mutat. 1, 166–168 (1992).
Kvittingen, E.A., Rootwelt, H., Berger, R. & Brandtzaeg, P. Self-induced correction of the genetic defect in tyrosinemia type I. J. Clin. Invest. 94, 1657–1661 (1994).
Brox, L, Ng, A., Pollock, E. & Belch. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin. Cancer Res. 44, 934–937 (1984).
Cohen, A. & Thompson, E. DNA repair in nondividing human lymphocytes: inhibition by deoxyadenosine. Cancer Res. 46, 1585–1588 (1986).
Kohn, D.B. et al. Selective accumulation of ADA gene-transduced T lymphocytes upon PEG-ADA dosage reduction after gene therapy with transduced CD34+ umbilical cord blood cells (abstract) Blood 86, 295 (1995).
Puck, J.M. X-linked immunodeficiencies. in Advances in Human Genetics Vol. 21 (eds Harris, H. & Hirschhorn, K.) 107–144 (Plenum Press, New York, 1993).
Rossiter, B.J.F. & Caskey, C.T., Phospho-ribosyltransferase deficiency: Lesch-Nyhan syndrome and gout, in The Metabolic Basis of Inherited Disease. 7th Edn. (eds Scriver, C., Beaudet, A.L., Sly, W.S. & Valle, D.) 1679–1706 (McGraw Hill, New York, 1995).
Hirschhorn, R., Roegner-Maniscalco, V. & Kuritsky, L. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J. Clin. Invest. 68, 1387–1393 (1981).
Hirschhorn, R. . et al. Increased excretion of modified adenine nucleosides by children with adenosine deaminase deficiency. Pediat. Res. 16, 362–369 (1982).
Hirschhorn, R., Yang, D.R. & Israni, A.J., AspSAsn substitution results in the Adenosine Deaminase (ADA) genetic polymorphism (ADA 2 Allozyme); occurrence on different chromosomal backgrounds and apparent intragenic crossover. Annls. Hum. Genet. 53, 1–9 (1994).
Tzall, S., Ellenbogen, A., Eng, F. & Hirschhorn, R. Identification and characterization of nine RFLP's at the adenosine deaminase (ADA) locus. Am. J. Hum. Genet. 44, 864–875 (1989).
Hirschhorn, R., V, Puck, J.& Douglas, S.D. Homozygosity for a newly identified missense mutation in a patient with very severe combined immunodeficiency disease due to adenosine deaminase deficiency. Am. J. Hum. Genet. 49, 878–885 (1991).
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K. & Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86, 2766–2770 (1989).
Tosato, G. Generation of Epstein-Barr virus (EBV)-immortalized B cell lines. Current Protocols in Immunology Vol. 7. (eds Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W.) 7.22.1–7.22.3 (John Wiley & Sons, New York, 1995).
Puck, J.M., Nussbaum, R.L., Smead, D.L. & Conley, M.E. X-linked severe combined immunodeficiency: localization within the region Xq13. 1-q21.1 by linkage and deletion analysis. Am. J. Hum. Genet. 44, 724–730 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirschhorn, R., Yang, D., Puck, J. et al. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 13, 290–295 (1996). https://doi.org/10.1038/ng0796-290
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0796-290
This article is cited by
-
Genetic Mosaicism as a Cause of Inborn Errors of Immunity
Journal of Clinical Immunology (2021)
-
Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization
Annals of Hematology (2020)
-
Somatic genetic rescue in Mendelian haematopoietic diseases
Nature Reviews Genetics (2019)
-
Mosaicism in health and disease — clones picking up speed
Nature Reviews Genetics (2017)
-
Severe combined immunodeficiencies and related disorders
Nature Reviews Disease Primers (2015)